Clinical trials
Completed Glioblastoma trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 9 |
| Hoffmann-La Roche | 4 |
| Eli Lilly and Company | 3 |
| Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 3 |
| Istituto Oncologico Veneto IRCCS | 3 |
| Novartis Pharmaceuticals | 3 |
| AbbVie | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| InSightec | 2 |
| Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 47 |
| Brain Neoplasms | 12 |
| Glioma | 9 |
| Gliosarcoma | 9 |
| Central Nervous System Neoplasms | 8 |
| Neoplasms | 5 |
| Astrocytoma | 4 |
| Colorectal Neoplasms | 3 |
| Oligodendroglioma | 3 |
| Stomach Neoplasms | 3 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.